The Changing Microbial Epidemiology in Cystic Fibrosis

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 2010 Apr 9

PMID 20375354

Citations 388

Authors

John J LiPuma

Affiliations

Soon will be listed here.

Abstract

Infection of the airways remains the primary cause of morbidity and mortality in persons with cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial species that are involved in respiratory tract infection in CF. The apparently expanding spectrum of species causing infection in CF and recent changes in the incidences and prevalences of infection due to specific bacterial, fungal, and viral species are described. The challenges inherent in tracking and interpreting rates of infection in this patient population are discussed.

Citing Articles

Dual RNA sequencing of a co-culture model of Pseudomonas aeruginosa and human 2D upper airway organoids.

Pleguezuelos-Manzano C, Beenker W, van Son G, Begthel H, Amatngalim G, Beekman J Sci Rep. 2025; 15(1):2222.

PMID: 39824906 PMC: 11742674. DOI: 10.1038/s41598-024-82500-w.

Complete genome sequence of the biopesticidal strain BCC0191.

Webster G, Mullins A, Mahenthiralingam E Microbiol Resour Announc. 2024; 14(2):e0109724.

PMID: 39665567 PMC: 11812388. DOI: 10.1128/mra.01097-24.

Interspecies interactions alter the antibiotic sensitivity of .

Koumans C, Tandar S, Liakopoulos A, van Hasselt J Microbiol Spectr. 2024; :e0201224.

PMID: 39495005 PMC: 11619387. DOI: 10.1128/spectrum.02012-24.

Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis.

Weyant R, Waddell B, Acosta N, Izydorczyk C, Conly J, Church D BMC Infect Dis. 2024; 24(1):1209.

PMID: 39465381 PMC: 11520053. DOI: 10.1186/s12879-024-10050-7.

Mechanisms of survival of trimethoprim-sulfamethoxazole-induced thymineless death.

Gonsalves L, Tran A, Gardiner T, Freeman T, Dutta A, Miller C mBio. 2024; 15(11):e0163424.

PMID: 39445807 PMC: 11559000. DOI: 10.1128/mbio.01634-24.

References

Coenye T, Falsen E, Hoste B, OHLEN M, Goris J, Govan J . Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol. 2000; 50 Pt 2:887-899. DOI: 10.1099/00207713-50-2-887. View

Coenye T, LiPuma J . Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J Infect Dis. 2002; 185(10):1454-62. DOI: 10.1086/340279. View

Olivier K, Yankaskas J, Knowles M . Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect. 1996; 11(4):272-84. View

Skov M, Mckay K, Koch C, Cooper P . Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Respir Med. 2005; 99(7):887-93. DOI: 10.1016/j.rmed.2004.11.018. View

Guarro J, Kantarcioglu A, Horre R, Rodriguez-Tudela J, Cuenca Estrella M, Berenguer J . Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol. 2006; 44(4):295-327. DOI: 10.1080/13693780600752507. View

Klinger J, Thomassen M . Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis. 1985; 3(2):149-58. DOI: 10.1016/0732-8893(85)90025-2. View

Kay S, Clark R, White K, Peel M . Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy. J Clin Microbiol. 2001; 39(2):808-10. PMC: 87828. DOI: 10.1128/JCM.39.2.808-810.2001. View

Collinson J, Nicholson K, Cancio E, ASHMAN J, Ireland D, Hammersley V . Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax. 1996; 51(11):1115-22. PMC: 1090523. DOI: 10.1136/thx.51.11.1115. View

Harris J, De Groote M, Sagel S, Zemanick E, Kapsner R, Penvari C . Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A. 2007; 104(51):20529-33. PMC: 2154465. DOI: 10.1073/pnas.0709804104. View

10.

McMenamin J, Zaccone T, Coenye T, Vandamme P, LiPuma J . Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest. 2000; 117(6):1661-5. DOI: 10.1378/chest.117.6.1661. View

11.

Liu L, Coenye T, Burns J, Whitby P, Stull T, LiPuma J . Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol. 2002; 40(4):1210-3. PMC: 140369. DOI: 10.1128/JCM.40.4.1210-1213.2002. View

12.

Talmaciu I, Varlotta L, Mortensen J, Schidlow D . Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr Pulmonol. 2000; 30(1):10-5. DOI: 10.1002/1099-0496(200007)30:1<10::aid-ppul3>3.0.co;2-q. View

13.

Shreve M, Butler S, Kaplowitz H, Rabin H, Stokes D, Light M . Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis. J Clin Microbiol. 1999; 37(3):753-7. PMC: 84543. DOI: 10.1128/JCM.37.3.753-757.1999. View

14.

Mahenthiralingam E, Vandamme P, CAMPBELL M, Henry D, Gravelle A, Wong L . Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis. 2001; 33(9):1469-75. DOI: 10.1086/322684. View

15.

Saiman L, Chen Y, Tabibi S, San Gabriel P, Zhou J, Liu Z . Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol. 2001; 39(11):3942-5. PMC: 88468. DOI: 10.1128/JCM.39.11.3942-3945.2001. View

16.

Palleroni N, BRADBURY J . Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol. 1993; 43(3):606-9. DOI: 10.1099/00207713-43-3-606. View

17.

Bakare N, Rickerts V, Bargon J, Just-Nubling G . Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses. 2003; 46(1-2):19-23. DOI: 10.1046/j.1439-0507.2003.00830.x. View

18.

Marchac V, Equi A, Le Bihan-Benjamin C, Hodson M, Bush A . Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients. Eur Respir J. 2004; 23(1):98-102. DOI: 10.1183/09031936.03.00007203. View

19.

Creech 2nd C, Kernodle D, Alsentzer A, Wilson C, Edwards K . Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005; 24(7):617-21. DOI: 10.1097/01.inf.0000168746.62226.a4. View

20.

Vandamme P, Coenye T . Taxonomy of the genus Cupriavidus: a tale of lost and found. Int J Syst Evol Microbiol. 2004; 54(Pt 6):2285-2289. DOI: 10.1099/ijs.0.63247-0. View